News tagged with adenocarcinoma
Pancreatic cancer diagnosis under review
A team of researchers of the UPV/EHU together with researchers from the Hospital Clínico of Barcelona have produced a bibliographical review that summarises the data currently existing on the markers for ...
Cancer
Apr 23, 2013 |
5 / 5 (1) |
0
Tumors with ALK rearrangements can harbor more mutations
The identification of potentially targetable kinase mutations has been an exciting advancement in lung cancer treatment. Although the mutations driving many lung carcinomas remain unknown, approximately 50 percent of lung ...
Cancer
Apr 22, 2013 |
not rated yet |
0
Misregulated genes common to tobacco-related cancers offer potential new prognostic tool
Believe it or not, while researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes. ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Fasting time for tumour cells
(Medical Xpress)—Tumours need a steady supply of sufficient nutrients to be able to grow. In order to secure the nutrient availability, they secrete messenger compounds to stimulate neighbouring blood vessels ...
Cancer
Mar 15, 2013 |
5 / 5 (2) |
0
|
Biomarkers may help predict progression of Barrett's esophagus to esophageal adenocarcinoma
A series of microRNA expression signatures that may help to define progression of the precancerous condition Barrett's esophagus into esophageal adenocarcinoma was reported recently in Cancer Prevention Research, a journa ...
Cancer
Mar 06, 2013 |
not rated yet |
0
Scientists find new molecule to target in pancreatic cancer treatment
Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often ...
Cancer
Jan 03, 2013 |
5 / 5 (2) |
0
|
Study confirms prognostic value of new IASLC/ATS/ERS adenocarcinoma sub-classification
The International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS), have proposed a new sub-classification of lung adenocarcinomas. A growing ...
Cancer
Dec 15, 2012 |
not rated yet |
0
Children born prematurely are at higher risk of esophageal inflammation, cancer
Infants that are born preterm or with impaired growth have an increased risk of developing gastroesophageal reflux disease (GERD), possibly leaving them vulnerable to the development of esophageal adenocarcinoma later in ...
Health
Dec 11, 2012 |
not rated yet |
0
Diltiazem relieves capecitabine-induced chest pain
(HealthDay)—Secondary prophylaxis with diltiazem may offer cancer patients relief from capecitabine-induced chest pain and dyspnea and allow them to tolerate capecitabine treatment, according to a study ...
Cardiology
Nov 16, 2012 |
5 / 5 (1) |
0
Risks of esophagus cancer studied: Statins may protect against esophageal cancer
Statin use is associated with protection from esophagus cancer according to a new meta-analysis of existing clinical studies exploring the cancer prevention effects of statins presented by a Mayo Clinic researcher, Dr. Siddharth ...
Cancer
Oct 22, 2012 |
not rated yet |
0
First WGS of multiple pancreatic cancer patients outlined in new study
Whole genome sequencing—spelling out all 3 billion letters in the human genome—"is an obvious and powerful method for advancing our understanding of pancreatic cancer," according to a new study from TGen, Mayo Clinic ...
Cancer
Oct 10, 2012 |
not rated yet |
0
|
Short-, long-course therapy comparable in T3 rectal cancer
(HealthDay)—There are no statistically significant differences in the rates of local recurrence (LR), distant recurrence, relapse-free survival, overall survival, or late toxicity in patients treated with ...
Cancer
Sep 27, 2012 |
not rated yet |
0
In lung cancer, smokers have 10 times more genetic damage than never-smokers
Lung cancer patients with a history of smoking have 10 times more genetic mutations in their tumors than those with the disease who have never smoked, according to a new study from Washington University School of Medicine ...
Cancer
Sep 13, 2012 |
5 / 5 (2) |
0
Characteristics of long-term gastric cancer survivors ID'd
(HealthDay)—Patients with gastric and gastroesophageal junction (GEJ) cancer who survive for longer than three years after diagnosis seem to have distinct demographic and pathologic characteristics, compared ...
Cancer
Sep 07, 2012 |
not rated yet |
0
ASGE initiative examines real-time imaging of Barrett's esophagus
The American Society for Gastrointestinal Endoscopy's (ASGE) Preservation and Incorporation of Valuable Endoscopic Innovations (PIVI) initiative examines real-time imaging of Barrett's esophagus in an article appearing in ...
Diseases, Conditions, Syndromes
Aug 27, 2012 |
not rated yet |
0
Adenocarcinoma
Adenocarcinoma is a cancer originating in glandular tissue. This tissue is also part of a larger tissue category known as epithelial. Epithelial tissue includes skin, glands and a variety of other tissue that lines the cavities and organs of the body. Epithelium is derived embryologically from ectoderm, endoderm and mesoderm. To be classified as adenocarcinoma, the cells do not necessarily need to be part of a gland, as long as they have secretory properties. This form of carcinoma can occur in some higher mammals, including humans. Well differentiated adenocarcinomas tend to resemble the glandular tissue that they are derived from, while poorly differentiated may not. By staining the cells from a biopsy, a pathologist will determine whether the tumor is an adenocarcinoma or some other type of cancer. Adenocarcinomas can arise in many tissues of the body due to the ubiquitous nature of glands within the body. While each gland may not be secreting the same substance, as long as there is an exocrine function to the cell, it is considered glandular and its malignant form is therefore named adenocarcinoma. Endocrine gland tumors, such as a VIPoma, an insulinoma, a pheochromocytoma, etc, are typically not referred to as adenocarcinomas, but rather, are often called neuroendocrine tumors. If the glandular tissue is abnormal, but benign, it is said to be an adenoma. Benign adenomas typically do not invade other tissue and rarely metastasize. Malignant adenocarcinomas invade other tissues and often metastasize given enough time to do so.
For more information about Adenocarcinoma, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.